Category: Trauson Holdings
Stryker (NYSE:SYK) CEO Kevin Lobo told an investors conference audience in Las Vegas yesterday that the medical device company is still in the mergers & acquisitions hunt, even after its newsmaking buyouts of China's Trauson Holdings, Israel's Orthovita and Surpass Medical.
Medical device company Stryker's purchase of Chinese spine-products maker Trauson Holdings is key to the company's emerging market strategy, company executives tell investors.
Stryker's (NYSE:SYK) is making moves to step up its game in emerging markets, widening its reach with the recent acquisition of Trauson Holdings, company officials told investors yesterday.
"The goal of this acquisition is to be able to leverage the product portfolio into other emerging markets," Katherine Owen, Stryker's vice president of strategy, said in a conference call with investors Wednesday.
Stryker agrees to pay $764 million to acquire Trauson Holdings, a Chinese medical device company that makes spinal and trauma care products.
Stryker (NYSE:SYK) made a HK$7.50-per-share cash bid for Trauson Holdings (HKG:0325), a Chinese medical device company that makes spinal and trauma care products.